Amerigen launches generic Targretin capsules

Amerigen Pharmaceuticals has introduced its generic Targretin capsules (bexarotene capsules). The drug is indicated to treat skin problems that arise from cutaneous T-cell lymphoma in patients who have not responded well to other treatments.

Amerigen’s generic Targretin capsules will be available in 75-mg dosage strength. It will be marketed by the Lyndhurst, N.J.-based arm of the company.